安捷凯在线客服
- 客服:
- 电话: 13061953619
- 微信:
Anti-Spike-RBD mAb 是一种 CHO 细胞来源的人源的单克隆抗体 IgG1,能够阻断 Spike 蛋白与 ACE2 的相互作用,从而达到潜在治疗 SARS-CoV-2 的目的。
Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of spike protein and ACE2 is a potential therapeutic approach for SARS-CoV-2 treatment[1].
[1]. Chunyan Wang, et al. A Human Monoclonal Antibody Blocking SARS-CoV-2 Infection. Nat Commun. 2020 May 4;11(1):2251.
动态评分
0.0